Cargando…

Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients

Detalles Bibliográficos
Autores principales:	Ruscheweyh, Ruth, Klonowski, Theresa, Goßrau, Gudrun, Kraya, Torsten, Gaul, Charly, Straube, Andreas, Jürgens, Tim Patrick, Scheidt, Jörg, Förderreuther, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288007/ https://www.ncbi.nlm.nih.gov/pubmed/35840895 http://dx.doi.org/10.1186/s10194-022-01453-5

Ejemplares similares

The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
por: Ruscheweyh, Ruth, et al.
Publicado: (2022)

Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry
por: Ruscheweyh, Ruth, et al.
Publicado: (2023)

Headache impact and socioeconomic status: findings from a study of the German Migraine and Headache Society (DMKG)
por: Müller, Britta, et al.
Publicado: (2023)

Physical Activity is Associated with Less Analgesic Use in Women Reporting Headache—A Cross-Sectional Study of the German Migraine and Headache Society (DMKG)
por: Müller, Britta, et al.
Publicado: (2022)

More Attacks and Analgesic Use in Old Age: Self-Reported Headache Across the Lifespan in a German Sample
por: Müller, Britta, et al.
Publicado: (2019)

Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe
por: Goßrau, Gudrun, et al.
Publicado: (2022)

Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe
por: Goßrau, Gudrun, et al.
Publicado: (2022)

Psychological factors associated with headache frequency, intensity, and headache-related disability in migraine patients
por: Klonowski, Theresa, et al.
Publicado: (2021)

Erratum zu: Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe
por: Goßrau, Gudrun, et al.
Publicado: (2023)

Use of outpatient medical care by headache patients in Germany: a population-based cross-sectional study
por: Müller, Britta, et al.
Publicado: (2020)

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Effectiveness of medication in cluster headache
por: Drescher, Johannes, et al.
Publicado: (2021)

Cluster Headache Impact Questionnaire (CHIQ) – a short measure of cluster headache related disability
por: Kamm, Katharina, et al.
Publicado: (2022)

Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review
por: Kaltseis, Katharina, et al.
Publicado: (2022)

Correlation of effectiveness and tolerability assessments from a pharmacy-based observational study investigating the fixed-dose combination of 400 mg ibuprofen plus 100 mg caffeine for the treatment of acute headache
por: Gaul, Charly, et al.
Publicado: (2023)

Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache
por: Gaul, Charly, et al.
Publicado: (2011)

Epidemiology of Headache in Children and Adolescents—Another Type of Pandemia
por: Nieswand, Vera, et al.
Publicado: (2020)

Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG)
por: Haag, Gunther, et al.
Publicado: (2010)

Impact of the Neck and/or Shoulder Pain on Self-reported Headache Treatment Responses – Results From a Pharmacy-Based Patient Survey
por: Gaul, Charly, et al.
Publicado: (2022)

Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients
por: Eren, Ozan E., et al.
Publicado: (2020)

Cluster headache attack remission with sphenopalatine ganglion stimulation: experiences in chronic cluster headache patients through 24 months
por: Barloese, Mads C. J., et al.
Publicado: (2016)

Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts
por: Ruscheweyh, Ruth, et al.
Publicado: (2020)

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study
por: Straube, Andreas, et al.
Publicado: (2023)

Botulinum toxin type-A therapy in cluster headache: an open study
por: Sostak, Petra, et al.
Publicado: (2007)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache
por: Jürgens, Tim P, et al.
Publicado: (2016)

Evaluating integrated headache care: a one-year follow-up observational study in patients treated at the Essen headache centre
por: Gaul, Charly, et al.
Publicado: (2011)

Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study
por: Gaul, Charly, et al.
Publicado: (2017)

Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache
por: Morris, James, et al.
Publicado: (2016)

Caffiene in Headache, (Migraine.)
por: Smith, T. Curtis
Publicado: (1874)

Migraine headache in Sudan
por: Ibrahim, Etedal Ahmed A., et al.
Publicado: (2021)

Migraine and Sick Headache
Publicado: (1905)

Brain-derived neurotrophic factor in primary headaches
por: Fischer, Marlene, et al.
Publicado: (2012)

Debate: Are cluster headache and migraine distinct headache disorders?
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2022)

Headache characteristics and postoperative course in Chiari I malformation
por: Thunstedt, Dennis C, et al.
Publicado: (2022)

Medication adherence in patients with cluster headache and migraine: an online survey
por: Rimmele, Florian, et al.
Publicado: (2023)

Olfactory training reduces pain sensitivity in children and adolescents with primary headaches
por: Gossrau, Gudrun, et al.
Publicado: (2023)

Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
por: Tfelt-Hansen, Peer
Publicado: (2007)

Oxygen Therapy in Cluster Headache, Migraine, and Other Headache Disorders
por: Mo, Heejung, et al.
Publicado: (2022)

Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study
por: Gaul, Charly, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ndgoifc7m6rj66ig5v6m2ndds6